(Q51487999)

5 April 2018

title

Biovariability of plasma adiponectin. (English)

1 reference

5 April 2018

4

Christopher Frampton

1 reference

5 April 2018

Peter Elder

2

object named as

Peter Elder

1 reference

5 April 2018

author name string

Brett Shand

1

1 reference

5 April 2018

Russell Scott

3

1 reference

5 April 2018

Jinny Willis

5

1 reference

5 April 2018

publication date

1 January 2006

1 reference

5 April 2018

Clinical Chemistry and Laboratory Medicine

published in

1 reference

5 April 2018

volume

44

1 reference

5 April 2018

issue

10

1 reference

5 April 2018

page(s)

1264-1268

1 reference

5 April 2018

Plasma adiponectin in overweight, nondiabetic individuals with or without insulin resistance

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.227

Unchanged fasting and postprandial adiponectin levels following a 4-day caloric restriction in young healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.227

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.227

Plasma adiponectin increases postprandially in obese, but not in lean, subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.227

Adiponectin: Identification, physiology and clinical relevance in metabolic and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.227

Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: the Funagata study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.227

Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.227

No postprandial increase of plasma adiponectin in obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.227

Adiponectin and protection against type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.227

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.227

Plasma adiponectin is an independent predictor of type 2 diabetes in Asian indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.227

Diurnal and ultradian dynamics of serum adiponectin in healthy men: comparison with leptin, circulating soluble leptin receptor, and cortisol patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.227

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.227

Adiponectin: Stability in Plasma over 36 Hours and Within-Person Variation over 1 Year

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2006.227

21 January 2018

Identifiers

DOI

10.1515/CCLM.2006.227

1 reference

5 April 2018

PubMed ID

17032140

1 reference

5 April 2018